H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Immunology D-index 95 Citations 76,484 148 World Ranking 329 National Ranking 207
Medicine D-index 97 Citations 77,477 162 World Ranking 4221 National Ranking 2389

Research.com Recognitions

Awards & Achievements

2019 - Distinguished Fellows of the American Association of Immunologists (AAI)

2013 - Member of the National Academy of Sciences

2010 - Fellow of the American Academy of Arts and Sciences

1996 - Fellow of the American Association for the Advancement of Science (AAAS)

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Immune system
  • Cytokine

Robert D. Schreiber spends much of his time researching Immunology, Immune system, Immunoediting, Cancer and Interferon gamma. Robert D. Schreiber interconnects Receptor and Cancer research in the investigation of issues within Immunology. His Immune system research includes themes of Mutation, Interferon, Cytotoxic T cell and Antigen.

His Immunoediting research integrates issues from Tumor Escape and Immunosurveillance. His biological study spans a wide range of topics, including Acquired immune system and Immunity. His Interferon gamma study combines topics from a wide range of disciplines, such as Cell culture, Lymphokine, Signal transduction, STAT1 and Monoclonal antibody.

His most cited work include:

  • How cells respond to interferons (3580 citations)
  • Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion (3431 citations)
  • Cancer immunoediting: from immunosurveillance to tumor escape. (3414 citations)

What are the main themes of his work throughout his whole career to date?

His primary scientific interests are in Immunology, Immune system, Cancer research, Molecular biology and Interferon gamma. His study on Immunology is mostly dedicated to connecting different topics, such as Cancer. His research integrates issues of Cancer cell and Interferon in his study of Immune system.

Robert D. Schreiber combines subjects such as Cell culture and Antibody with his study of Molecular biology. His research investigates the connection between Interferon gamma and topics such as Receptor that intersect with problems in Signal transduction and Transfection. The various areas that Robert D. Schreiber examines in his Immunoediting study include Tumor Escape and Immunosurveillance.

He most often published in these fields:

  • Immunology (45.10%)
  • Immune system (22.35%)
  • Cancer research (20.39%)

What were the highlights of his more recent work (between 2011-2021)?

  • Immunology (45.10%)
  • Cancer research (20.39%)
  • Immune system (22.35%)

In recent papers he was focusing on the following fields of study:

His primary areas of study are Immunology, Cancer research, Immune system, Antigen and Cancer. His work on Cytotoxic T cell expands to the thematically related Immunology. His studies in Cancer research integrate themes in fields like Receptor, Follicular lymphoma and Breast cancer, Estrogen receptor, Estrogen receptor alpha.

His Immune system research includes elements of Cancer cell and Interferon. His Antigen study incorporates themes from Interferon gamma and Tumor antigen. Robert D. Schreiber does research in Cancer, focusing on Tumor progression specifically.

Between 2011 and 2021, his most popular works were:

  • Neoantigens in cancer immunotherapy (2328 citations)
  • Checkpoint blockade cancer immunotherapy targets tumour-specific mutant antigens (1142 citations)
  • Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression (1132 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Immune system
  • Cytokine

The scientist’s investigation covers issues in Immunology, Immune system, Antigen, Cancer and Cancer research. The concepts of his Immunology study are interwoven with issues in Cytotoxic T cell and Blockade. His study in Cancer immunotherapy, Immunotherapy, Immunoediting, Acquired immune system and Immunogenicity are all subfields of Immune system.

His Antigen research incorporates themes from Tumor progression and In vivo. Within one scientific family, he focuses on topics pertaining to Glycolysis under Tumor progression, and may sometimes address concerns connected to Interferon gamma. His studies deal with areas such as Immune checkpoint, Transcriptome, CD1D and Mass cytometry as well as Cancer research.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

How cells respond to interferons

George R. Stark;Ian M. Kerr;Bryan R. G. Williams;Robert H. Silverman.
Annual Review of Biochemistry (1998)

4814 Citations

Cancer immunoediting: from immunosurveillance to tumor escape.

Gavin P. Dunn;Allen T. Bruce;Hiroaki Ikeda;Lloyd J. Old.
Nature Immunology (2002)

4726 Citations

Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death

David Hockenbery;Gabriel Nuñez;Curt Milliman;Robert D. Schreiber.
Nature (1990)

4706 Citations

Cancer Immunoediting: Integrating Immunity’s Roles in Cancer Suppression and Promotion

Robert D. Schreiber;Lloyd J. Old;Mark J. Smyth;Mark J. Smyth.
Science (2011)

4370 Citations

IFNγ and lymphocytes prevent primary tumour development and shape tumour immunogenicity

Vijay Shankaran;Hiroaki Ikeda;Allen T. Bruce;J. Michael White.
Nature (2001)

3043 Citations

The three Es of cancer immunoediting.

Gavin P. Dunn;Lloyd J. Old;Robert D. Schreiber.
Annual Review of Immunology (2004)

2724 Citations

The immunobiology of cancer immunosurveillance and immunoediting

Gavin P. Dunn;Lloyd J. Old;Robert D. Schreiber.
Immunity (2004)

2724 Citations

Neoantigens in cancer immunotherapy

Ton N. Schumacher;Robert D. Schreiber.
Science (2015)

2459 Citations

Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway

Marco A Meraz;Marco A Meraz;J.Michael White;Kathleen C.F Sheehan;Erika A Bach.
Cell (1996)

1827 Citations

Natural Innate and Adaptive Immunity to Cancer

Matthew D. Vesely;Michael H. Kershaw;Robert D. Schreiber;Mark J. Smyth.
Annual Review of Immunology (2011)

1768 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Robert D. Schreiber

Jean-Laurent Casanova

Jean-Laurent Casanova

Rockefeller University

Publications: 231

Mark J. Smyth

Mark J. Smyth

QIMR Berghofer Medical Research Institute

Publications: 217

Guido Kroemer

Guido Kroemer

Sorbonne University

Publications: 167

Laurence Zitvogel

Laurence Zitvogel

Institut Gustave Roussy

Publications: 162

Laurent Abel

Laurent Abel

Inserm : Institut national de la santé et de la recherche médicale

Publications: 140

Lorenzo Galluzzi

Lorenzo Galluzzi

Cornell University

Publications: 111

Jérôme Galon

Jérôme Galon

Université Paris Cité

Publications: 110

Kenneth M. Murphy

Kenneth M. Murphy

Washington University in St. Louis

Publications: 99

Jedd D. Wolchok

Jedd D. Wolchok

Memorial Sloan Kettering Cancer Center

Publications: 97

Stéphanie Boisson-Dupuis

Stéphanie Boisson-Dupuis

Rockefeller University

Publications: 96

Francis V. Chisari

Francis V. Chisari

Scripps Research Institute

Publications: 90

John J. O'Shea

John J. O'Shea

National Institutes of Health

Publications: 83

Catherine Sautès-Fridman

Catherine Sautès-Fridman

Université Paris Cité

Publications: 78

Leonidas C. Platanias

Leonidas C. Platanias

Northwestern University

Publications: 75

Shizuo Akira

Shizuo Akira

Osaka University

Publications: 72

Hideo Yagita

Hideo Yagita

Juntendo University

Publications: 70

Something went wrong. Please try again later.